• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    Instrumentation Innovations: A Review of Instrument Manufacturing

    The Total Package: Packaging and Sterilization for Orthopedics

    Helping Nature Take Its Course: A Biologics Breakdown

    Making the Grade: Orthopedic Materials Spotlight

    Mending Mishaps: A Trauma Technology Overview
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System

    Kaia Health Unveils Next-Gen Complete MSK Care Solutions

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower

    NuVasive Nabs Simplify Medical for $150M

    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower

    NuVasive Nabs Simplify Medical for $150M

    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody

    Nexus Spine Implants for Use in Spinal Surgeries Become Available
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Solutions from Man’s Best Friend

    The FDA’s Flip-Flop on Hyaluronic Acid

    HSS, Zimmer Biomet's Solution for the Episode of Orthopedic Care

    Rising to the Challenge: Q&A with AAOS Second VP Dr. Savoie

    Teleconferencing in the OR
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tiodize

    Autocam Medical

    Tecomet

    Lowell Inc.

    Sayan Orthopaedics Ltd.
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    A Supply Chain Strategy for Pandemic Survival

    Medical device supply chain managers will likely conclude that 2020 is a year best forgotten.

    Tony Freeman, President, A.S. Freeman Advisors LLC11.18.20
    Medical device supply chain managers will likely conclude that 2020 is a year best forgotten. After an early continuation of 2019’s strong sales, the arrival of COVID-19 crippled order books throughout the spring and summer. While few companies lost OEM customers, almost all organizations experienced supply delays or backlogs. At the start of the fall, orders began trickling in again but the damage is done. 2020 will see most supply chain players with revenues 10 percent to 20 percent below last year’s levels. Despite lower profits, however, long-term gains will return for medtech firms willing to learn from the pandemic-induced demand shock. The following four measures will benefit most any company.

    Survive by Managing Cash and Inventory
    Surprisingly, many otherwise hard-headed managers assumed the global pandemic slowdown would end fairly quickly. In May, most medtech executives believed the U.S. economy would be back on track by September, though few supported their optimism with facts. That confidence likely stemmed from a misguided but nevertheless widely-accepted belief about the device industry’s immunity to recession. Many U.S. firms took out Payroll Protection Plan (PPP) loans, assuming the funds would prove to be a windfall. Few companies took a hard look at cash management to ensure they could operate sustainably through hard times. Let’s face it—in the past they never had to.

    The industry is now experiencing the consequences of failing to conserve cash. PPP loans are being used to cover payrolls, and both accounts receivable and payable days outstanding are trending up. Cuts in staff, capital purchases, and marketing budgets have begun. Non-critical repairs are being delayed as are long-term critical expenses like product launches. This process has largely transpired under the radar but has attracted notice recently because companies are running down cash balances and spending government grants.

    Another unwise business strategy that companies have frequently deployed this year involves using idled staff to build future inventory. The approach makes sense only if a manufacturer knows for certain when the inventory will be sold. With the pandemic’s unpredictable timeline, suppliers may be unnecessarily burning much-needed cash to create inventory that may end up sitting on shelves due to low demand.

    The lesson here is that cash is like blood. A person can lose blood and survive but his recovery is tied to the amount of blood lost. Suppliers that carefully conserving cash from the start of the pandemic will have more opportunities to take market share from competitors as demand returns to normal.

    Avoid False Expectations
    Medical device supply chain managers tend to be realists. Most come from engineering or business backgrounds, disciplines that favor hard facts over unfounded hope. Surprisingly, the early months of the pandemic saw remarkably rosy expectations of a return to booming business in the fall. No reasons were offered, it was just expected that progress would prevail. This “magical thinking” was not unique to the medical device industry. Everyone hoped the problem would go away. There was comfort in jointly pronouncing such pleasurable thoughts in a frightening, confusing time. Yet anyone who passed high school biology knows respiratory viruses are highly contagious. There is no clear explanation for why so many managers expected an early end to the problem despite evidence the virus is difficult to control. Looking forward, managers should recognize that a vaccine won’t quickly end the pandemic, as it will take at least a year to inoculate 70 percent of the population to avoid a large-scale resurgence of the disease. Thus, COVID-19 precautions will be necessary for many months to come.

    Besides hopes for an early recovery in orders, mangers at several U.S. supply chain companies suggested the pandemic would lead to reshoring of medical manufacturing. Such hopeful thinking stood in contrast to the extent and depth of America’s contagion. Further, it did not address the cost advantage that originally prompted U.S. medtech manufacturers to outsource work to other countries. Certainly, COVID-19 has not altered the global labor arbitrage. Assuming the virus alone will spark massive reshoring efforts is unproductive.

    Exceptional Communication is Necessary
    The early days of COVID-19 in March saw confusing, contradictory, and often wrong information circulated by governments and media outlets. In crises, only a minority of people remain calm. Leaders of supply chain companies did not have the option of panicking. Their employees, suppliers, and customers turned to them for guidance in an unprecedented situation.

    Most managers rose to the challenge. The initial focus was inside their facilities. Supply chain leaders instituted sanitary practices and communicated them clearly to their employees. As scientific understanding of the virus increased, managers did not hesitate to change their instructions. Most stayed in regular contact with their staffs and made themselves available one-on-one to calm the concerned or make accommodations for employees with special needs.

    Less effective was the supply chain’s communications with constituencies outside their walls. Most company websites contained COVID-19 messages that relayed basic information, though executives at many firms reached out to customers and suppliers to explain their firms’ operational status. Yet few supply chain company managers used the chaotic situation as an opportunity to reinforce their firm’s resilience and dedication to customers, and to inquire how they could better support customers during the pandemic. Too often the discussions centered around, “yes, we are open” and “can you share the revised forecast, for whatever it may be worth?”

    The chance for supply chain companies to set themselves apart from competitors through good communication still exists. OEMs continue to struggle with diminished revenues. Rather than seeking the usual information, supply chain managers would be well-served to question customers about their current pain points and how the supplier might relieve them. A particularly rich opportunity exists for companies capable of managing other supply chain partners to offer supplier management services to OEMs.

    Retain and Train Staff
    Prior to the pandemic, supply chain companies recognized that skilled staff was nearly impossible to find. High turnover was practically guaranteed due to quality problems, delays, and lost opportunities.

    COVID-19, however, added a new challenge in staff management: Fear of being in the workplace, as well as child and elder care issues led to daily absenteeism exceeding 20 percent at some northeastern firms in March and April.

    Supply chain company managers have generally done an excellent job retaining staff. Most firms have shown flexibility regarding hours and family leave. Layoffs and furloughs have been avoided even though 2020 profits will suffer. If “normal” levels of business return in the first half of 2021, supply chain firms will be rewarded with solid rosters of irreplaceable workers.

    Keeping staff employed in hard times is a complex balancing act. Labor costs are manufacturers’ largest expense. With lower than expected order activity and declining cash balances, there will be justified temptation to reduce staff. But forward-looking supply chain firms should do all they can to resist layoffs for as long as possible.

    Despite the challenges of the pandemic there is an opportunity for workforce improvement. In place of building inventories, this period may be used for training in new skills and capabilities. As consolidation increases competition between suppliers, a refreshed and/or reinforced set of manufacturing capabilities may be key to winning the next major customer or project. Supply chain firms should use the extra time they have now to build a more capable company for the future.

    Balancing Reactive and Proactive Strategies
    To date, medical device supply chain companies have survived the pandemic, as no bankruptcies have been reported. Additionally, the acquisitions market remains white-hot with historically high multiples testifying to investor confidence in the field. Much of the resilience seen in supply chain companies has resulted from how well management teams reacted in the spring. As previously. mentioned, few companies have attempted to capitalize on the challenges COVID-19 is creating for OEMs. The focus has been “We’re still here” rather than “We have a better way to do things now that we all face difficult times.” Prior to the pandemic, firms stressed nimbleness, quality, and a range of manufacturing services. During COVID-19’s reign, suppliers will benefit from describing resilient manufacturing strategies or offering to absorb OEM risk in exchange for control over more of the supply chain than just the customer’s component stream.

    As supply chain managers judiciously react to new developments in the pandemic, some time should be spent looking for the opportunities created by disruptions in OEM business-as-usual polices and approaches. While possibly modest, they allow a contract manufacturer a better position in an increasingly competitive landscape.

    In the meantime, stay healthy. 


    Tony Freeman is the president of A. S. Freeman Advisors LLC, a mergers, acquisitions, and strategic consulting company focused the specialty materials and precision manufacturing industries. Questions or comments on this article can be addressed to tfreeman@asfreeman.com.

    Related Columns

    • Striving to Attain a Gain on the Pain

      Striving to Attain a Gain on the Pain

      A growing number of orthopedic patients are wrestling with fear, perhaps fueled in part by variant virus strains believed to be more contagious.
      Michael Barbella, Managing Editor 02.08.21

    • Rethink Your Orthopedic ASC Strategy, Part 1

      Rethink Your Orthopedic ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.08.21

    • Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, Founder & President, Empirical 02.08.21


    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.08.21

    • Biologics
      An FDA Regulatory Perspective on Bone Grafts

      An FDA Regulatory Perspective on Bone Grafts

      There are various bone grafts with different composition, source, mechanical strength, and functional biological mechanisms.
      Mehdi Kazemzadeh-Narbat, Ph.D., Senior Associate, Regulatory Affairs, MCRA LLC 02.08.21

    • Packaging & Sterilization
      Building a More Transparent Healthcare Supply Chain with UDI

      Building a More Transparent Healthcare Supply Chain with UDI

      The FDA’s 2013 Unique Device Identification (UDI) Rule sets specific requirements for medical device labeling to improve traceability and patient safety.
      Beth Wells, Senior Director, Community Engagement, Healthcare, GS1 US 02.08.21


    • Stryker Strikes Back After Pandemic Slump

      Stryker Strikes Back After Pandemic Slump

      Late last year, Stryker announced it would snap up Wright Medical to fortify its position in the trauma and extremities markets.
      Sam Brusco, Associate Editor 11.18.20

    • Large Joint
      Obesity and the Impact on Hip and Knee Implants

      Obesity and the Impact on Hip and Knee Implants

      Obesity causes multiple health issues, and the COVID-19 pandemic is only adding to the problem.
      Maria Shepherd, President and Founder, Medi-Vantage 11.18.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.18.20


    • 13 Mistakes to Avoid in a 510k Submission

      13 Mistakes to Avoid in a 510k Submission

      The FDA 510(k) review process can broadly be divided into two steps—acceptance review and substantive review.
      Samradni Patil, Regulatory Consultant and Writer, Kolabtree 11.18.20

    • Medical Device Equivalence Requirements Strengthened under the EU MDR

      Medical Device Equivalence Requirements Strengthened under the EU MDR

      This column focuses on the directive under EU 2017/745 on medical devices (MDR), highlighting some of the changes in claiming and demonstrating equivalence.
      Cindy Boyer, Senior Manager, International Regulatory Affairs, MCRA LLC 11.18.20

    • Solid Footing During Shaky Times: Current Compliance Considerations

      Solid Footing During Shaky Times: Current Compliance Considerations

      The changes and challenges wrought by COVID-19 have significantly impacted the medtech industry.
      Bryan Brosseau, Founder and Principal Consultant, Brosseau Consulting LLC 11.18.20


    • A Wrinkle in the COVID-19 Financial Recovery

      A Wrinkle in the COVID-19 Financial Recovery

      A British Journal of Surgery study projected the global pandemic would postpone or outright cancel 6.3 million orthopedic procedures.
      Michael Barbella, Managing Editor 09.15.20

    • Research & Development
      Trends for Orthopedic Contract R&D and Manufacturing

      Trends for Orthopedic Contract R&D and Manufacturing

      Over the past 10 years, medtech manufacturers from startups to giants have grown their levels of outsourcing to contract R&D and manufacturing partners.
      Maria Shepherd, President and Founder, Medi-Vantage 09.15.20

    • Self-Care in Business: Four Ways to Extend the Peace of Home to the Workplace

      Self-Care in Business: Four Ways to Extend the Peace of Home to the Workplace

      Like so many small business owners, the lines between work and home often blur in the Lissy household.
      Dawn A. Lissy, Founder & President, Empirical 09.15.20


    Trending
    • FDA OKs Brainlab's Loop-X Mobile Imaging Robot, Cirq Robotic Alignment Module
    • NuVasive Nabs Simplify Medical For $150M
    • Mini MRI For Hand And Wrist Imaging Can Be Used Nearly Anywhere
    • Mini MRI for Hand and Wrist Imaging Can Be Used Nearly Anywhere
    • Orchid Appoints CCO
    Breaking News
    • Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    • Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    • First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    • NuVasive Nabs Simplify Medical for $150M
    • SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Instrumentation Innovations: A Review of Instrument Manufacturing
    • The Total Package: Packaging and Sterilization for Orthopedics
    • Helping Nature Take Its Course: A Biologics Breakdown
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    Cosmetic Chemical Sales To Post CAGR 5.8% To 2025
    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login